Navigation Links
MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
Date:4/7/2011

AZUSA, Calif., April 7, 2011 /PRNewswire/ -- MEDomics, LLC provides NextGen sequence-based DNA diagnostic testing to enable personalized medicine in the genomics era and is transforming diagnostic testing for mitochondrial diseases.  MEDomics is proud to announce a growth capital investment from our partner, SpaGus Ventures LLC.  This second capital infusion from SpaGus will be used by MEDomics to fuel the continued growth of the company's industry leading tests for mitochondrial disease diagnosis (MitoDx and MitoNucleomeDx), that have produced over $2M in sales over a few months of limited release in the market.  In addition, Gary Augusta will become COO, join the MEDomics Board and lead the Corporate Development initiatives as the company adds senior leadership.

"We are pleased to continue and advance our relationship with SpaGus Ventures and Gary. The MitoDx and MitoNucleomeDX tests have got great traction in our target market and having Gary on board as an experienced partner further augments our senior business leadership," states Dr. Steve Sommer, Founder and President of MEDomics.

Gary Augusta states, "I am both honored and excited to invest in and work with the MEDomics team. What Dr. Sommer and the MEDomics team have accomplished is incredible and I look forward to contributing to the growth of this company and helping the patient community."

Mr. Augusta has over 20 years of experience as a CEO, CFO, growth capital investments, M&A and corporate development, angel and venture/micro private equity investing, strategy and operations management for small to Fortune 500 companies. SpaGus Ventures LLC is a fund focused on equity and debt investing for "unique" biomedical and technology companies with $1M-$10M of revenues who need capital for growth; typically for companies to "reach the next gate" of product or commercialization.  

MEDomics, LLC (www.medomics.com) is a molecular diagnostic laboratory that was founded in 2008 by Steve S. Sommer, MD, PhD, with the mission of providing Mutation Expert-based Diagnosis ("MED") to support the physician in delivering personalized medicine based on analysis of the patient's genome ("omics"). MEDomics was the first CLIA Certified Laboratory specializing in the clinical diagnostic application of Next Generation sequencing. The mutation experts at MEDomics provide quality interpretation to aid the practicing physician.  The staff at MEDomics "live and breathe" mitochondrial medicine.

Contact Information:
Jessica Thompson, Spaulding Thompson & Associates for MEDomics, LLC
949-233-8575, jessica@spauldingthompson.com

426 N. San Gabriel Ave.
Azusa, CA 91702
www.medomics.com
Phone: (626) 804-3645


'/>"/>
SOURCE MEDomics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
2. Mtech Announces Finalists for University of Maryland $75K Business Plan Competition
3. Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders
4. Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste
5. Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting
6. BioLife Solutions Announces Record Quarterly Revenue
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results
9. Medicomp, Inc. Announces Company Purchase From United Therapeutics
10. CareFusion Announces Departure of Chief Operating Officer
11. Danaher Announces Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 - bioLytical lanza el ... directrices de la OMS     Continue Reading ... ... , , ... infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV ...
(Date:12/2/2016)... , December 2, 2016 ... global cardiac pacemaker market in its upcoming report titled, "Global Market Study ... a Declining CAGR of -1.4% between 2016 and 2024". The ... Mn in 2015 and this is likely to decline ... revenue, the global cardiac pacemaker market is anticipated to ...
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary device ... in the Emergency Response Training and Support Services (ERTSS) ... to have LifeVac become part of the ERTSS mission ... and CEO of LifeVac. "Having an established network of ... effectively will help leverage our efforts to spread LifeVac,s ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
(Date:12/2/2016)... Delaware (PRWEB) , ... December 02, 2016 , ... ... released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps ... sample entry through labeling, storing, shipping and disposal. The new version is a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The ... how this current generation fits into Bible Prophecy. Yisrayl says this generation, known as ... to this conclusion, showing how the details line up exactly with Bible Prophecy – ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s Manual, ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ...
Breaking Medicine News(10 mins):